A MedUni Vienna research team has developed a new blood test that indicates a person's status of cellular immunity to SARS-CoV-2 within just 48 hours. This test is particularly relevant for vulnerable patient groups, whose ...
Jul 20, 2022
0
30
When asthmatics' respiratory tracts are exposed to dust mites, their immune response becomes less effective, which can lead to a weaker immune system. People who suffer from asthma associated with infection may therefore ...
Jun 17, 2022
0
7
Australian researchers have discovered the key immunological changes that support the remission of peanut allergy in children, paving the way for new, more targeted treatments.
May 25, 2022
0
24
Peanut allergy can be deadly, and evidence shows that it affects nearly 2% of people in some Western countries. While the standard treatment for peanut allergy is to avoid exposure, oral immunotherapy is a heavily debated ...
Apr 26, 2022
0
5
The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it is effective against all SARS-CoV-2 variants known to date, including omicron—even in those who have not yet ...
Apr 5, 2022
0
297
Although sublingual immunotherapy (SLIT) has become an effective treatment option for many allergies, about 20–30% of patients don't respond to SLIT for Japanese cedar pollinosis—a highly common disease. In a recent study, ...
Mar 7, 2022
0
4
There is virtually no protection against infection with the currently circulating omicron variant of the SARS-CoV-2 virus for dual-vaccinated and recovered individuals who were infected with the previous SARS-CoV-2 variants. ...
Feb 22, 2022
0
18
Allergies and many other types of immune system-related diseases originate from an interplay of complex chemical pathways that affect cell behavior, distribution, and development. One prominent example is the CCL17/TARC chemokine, ...
Dec 13, 2021
0
1
Around 20% of those who have recovered from COVID-19 fail to develop immune protection against SARS-CoV-2, according to a MedUni Vienna research team led by allergist and immunologist Rudolf Valenta from the Center for Pathophysiology, ...
Aug 30, 2021
0
316
A century-old tuberculosis vaccine could help reduce the incidence of eczema in high-risk infants due to its beneficial off-target effects, according to a new MCRI-led allergy study.
Aug 24, 2021
0
156
